Showing 1471-1480 of 18587 results for "".
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
https://reachmd.com/programs/neurofrontiers/comprehensive-care-navigating-neurobehavioral-issues-in-dmd-patients/16502/Here are some best practices for managing the 70 percent of patients with Duchenne muscular dystrophy who also have a neurobehavioral issue.The Future of Immunotherapy: Advancing Care in Endometrial Cancer
https://reachmd.com/programs/project-oncology/future-immunotherapy-endometrial-cancer/39932/Immunotherapy is a key treatment option for advanced and recurrent endometrial cancer, yet response rates remain variable—even in patients with mismatch repair-deficient tumors. Hear from Dr. Casey Cosgrove as he explores emerging strategies to enhance immune responsiveness, better predict trQuality of Life and the Mental Toll of Itch
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37179/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, addresses the psychological impact of itch and how it can affect a patient’s overall quality of life.Improving Lipid Management Through Equity-Focused Clinical Strategies
https://reachmd.com/programs/heart-matters/improving-lipid-management-through-equity-focused-clinical-strategies/37598/Despite advances in lipid-lowering therapies, disparities in hyperlipidemia diagnosis and treatment persist. Dr. Keith Ferdinand examines how social drivers of health impact access, adherence, and outcomes and explains how clinicians can help address gaps in care for underserved populations. Dr. FerOverview of the Latest Guidance in IgA Nephropathy Management
https://reachmd.com/programs/kdigo-conversations-nephrology/overview-of-the-latest-guidance-in-iga-nephropathy-management/37115/On this first episode of the KDIGO IgA Nephropathy (IgAN) podcast series, join host Dr. Dana Rizk and special guest Dr. Brad Rovin for a discussion on the latest guidance for managing IgAN. As an expert in glomerular diseases and co-chair of the KDIGO Glomerular Disease Guideline Working Group, Dr.Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-immune-checkpoint-inhibitor-colitis-effectively/32873/Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang.Boosting Colorectal Cancer Screening in Rural Clinics: Insights from SMARTER CRC
https://reachmd.com/programs/clinicians-roundtable/boosting-colorectal-cancer-screening-in-rural-clinics-insights-from-smarter-crc/36409/The SMARTER CRC trial evaluated mailed fecal immunochemical (FIT) outreach and patient navigation strategies across rural clinics, analyzing how implementation factors like clinic-sent letters, consistent FIT usage, and active participation in health plan meetings impacted screening outcomes. Two auImproving Metastatic Breast Cancer Care Through Integrated Palliative Support
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/improving-metastatic-breast-cancer-care-through-integrated-palliative-support/36436/A 2025 study conducted at Champalimaud Clinical Center’s Breast Unit in Portugal explored the impacts of a fully embedded palliative care model for patients with metastatic breast cancer. In this AudioAbstract, Mr. Ryan Quigley dives into the findings on how proactive, integrated support may enhEvaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
https://reachmd.com/programs/dermconsult/evaluating-guselkumab-for-pediatric-psoriasis-new-phase-iii-trial-data/32450/The phase III PROTOSTAR study published in the Journal of the American Academy of Dermatology in March 2025 highlights new findings on the efficacy and safety of guselkumab for pediatric psoriasis. Join Dr. Amy Paller as she reviews the data and its implications for the future of pediatric psoriasisIdentifying C3G: Key Diagnostic Considerations and Challenges
https://reachmd.com/programs/frontlines-c3g/identifying-c3g-key-diagnostic-considerations-and-challenges/35487/Complement 3 glomerulopathy (C3G) presents complex diagnostic hurdles due to its rarity, clinical heterogeneity, and lack of definitive biomarkers. Tune in to hear Dr. Gates Colbert and Dr. Anuja Java discuss the need for improved biomarker development, our evolving understanding of complement dysre